Name: International Life Sciences & Biotech Conference
Start: 2025-09-10T09:00:00-07:00
End: 2025-09-11T13:00:00-07:00
Location: Hilton San Diego Bayfront

Tickets

General Admission

$550.00 /ticket

Get your ticket today.

Buy Tickets

What You Get:

Access to expert panel discussions featuring leading developers, biotech executives, investors and policymakers.
Targeted networking sessions designed to connect industry leaders, innovators and decision-makers.
Keynote presentations and roundtable discussions on the most pressing topics impacting biotech and real estate.
Evening cocktail receptions to foster meaningful connections and partnerships.
Breakfast, lunch, snacks and beverages on day one and breakfast and snacks on day two.

Group Tickets

$400.00 /ticket

Save when you register 3+ attendees

Buy Tickets

Get the best rate when you bring a group

Speakers and Panels

Keynote & Award Ceremony

A Conversation with Timothy Schoen, CEO, BioMed Realty

Keynote

Timothy Schoen

CEO, BioMed Realty

Driving Sustainability in Life Sciences and Biotech

Implementing Sustainable Operational Solutions, Navigating Global Challenges, and Building Adaptable, Efficient Infrastructure to Support Real Estate Growth

Joydeep Ganguly

Joydeep Ganguly serves as Senior Vice President of Corporate Operations at Gilead Sciences. In his current role, he is accountable for several strategic functions, including corporate engineering; capital and infrastructure strategy; corporate real estate; risk management; operations research and global procurement. Serving as the Chief Sustainability Officer for the organization, Joydeep also leads Gilead’s environmental sustainability strategies globally. He is a member of the company’s executive ESG committee, as well as a Board member of the Gilead Foundation. Prior to Gilead, Joydeep spent 10 years at Biogen, in roles of increasing responsibility in the areas of process sciences, manufacturing and supply chain. In his role as Vice President and Global Head of Biogen’s Technical Operations function, he oversaw the company’s multi-scale biologics and small molecule operations, as well as led general operations for the company’s presence in North Carolina, Denmark and Switzerland. A past board member of the North Carolina Biosciences Organization (NCBIO) and the North Carolina Museum of Life and Sciences, he currently serves on the Board of Directors of Bay Area Council, Biocom,  and is a trustee at Town School for Boys. He also serves on the Board of Advisors for Culture Biosciences, as well on the Advisory Council for NC State University’s Supply Chain research program. He earned an M.S. in Electrical Engineering from the University of Notre Dame, an M.B.A. from North Carolina State University, and an MHA from Cornell University where he received the prestigious Sloan award. Joydeep has been recognized by the National Diversity Council as a Top 50 Diverse Leader in California, awarded the Leadership Excellence Award by the California Diversity Council, and was recently named as one of the Top 3 leaders in Climate Science within the Biotech industry.

Gilead Sciences

Chief Sustainability Officer and SVP, Global Ops

Joydeep Ganguly

Chief Sustainability Officer and SVP, Global Ops, Gilead Sciences

Katie Sheehan

Director, Sustainability, Breakthrough Properties

Justin Dunn

VP of Sustainability, SteelWave

John Swift

Partner, Buro Happold

Isabel Mandujano

Director of Lab Planning, LPA Design Studios

William Silva

Director, Preconstruction, Swinerton

Moderator

Kurt Lindorfer

Founding Principal, PARADIGM Structural Engineers

Development, Construction, and Design Strategies Across All Lab Types

Meeting Market Demands and Tenant Expectations in an Evolving Life Sciences Market

Mark Watkins

Senior Director, Global Real Estate, Thermo Fisher Scientific

Sonia Taneja

Managing Director, King Street Properties

Chris Tipre

Principal, Trammell Crow Company

Jeff West

Vice President, Facilities & Campus Operations, Fred Hutch

Elizabeth Hawkins

Operations Manager, Swinerton

Helping Life Sciences Companies Scale

Building Ecosystems, Identifying Clusters, Propelling Startup Growth and Expansion, and Helping Biotech Firms Reach Their Next Stage

Chris Haskell, Ph.D.

Chris has responsibility for all aspects of the JLABS @ San Francisco Bay Area, as well as supporting the broader ecosystem through external presence and partnerships. He leads sourcing and diligence for JLABS portfolio companies in alignment with J&J focus areas to assess strategic fit. He collaborates with the broader JJI organization, in particular the JJI West North America regional team, to position and enable partnerships and investments between J&J and JLABS companies to strengthen the innovation pipeline. He leads the JLABS @ San Francisco Bay Area team, with responsibility for site operations and budget. Chris joined JLABS from Bayer’s West Coast Open Innovation Center. The Open Innovation Center supported Bayer’s Drug Discovery activities by developing and managing partnerships with U.S. academic research institutions and life science companies. Chris was also responsible for cultivating life science startups within the CoLaborator, a biotech incubator space developed to foster collaboration between Bayer and emerging innovators. Concurrent with this role, Chris actively participated in the local Bay Area startup ecosystem, contributing to various initiatives that aimed to support the growth and success of early biotech companies. He has served as a mentor in various startup support programs affiliated with organizations such as QB3, SkyDeck, and the California Life Science FAST program. In addition, Chris served as Chair of the California Life Science Institute’s Board of Advisors. This organization (now merged with California Life Sciences) plays a crucial role in fostering entrepreneurship, science education, and workforce development in the San Francisco Bay Area. In previous roles at Bayer, Chris held various scientific leadership positions in drug development, including the Acting Head of Applied Research, the unit responsible for hemostasis research and drug development. Following the founding of the Open Innovation group, Chris directed a group that led alliances between Bayer and early innovators in the biotech and academic sectors, including programs in gene therapy, ophthalmology, oncology and cardiovascular disease. Chris earned his PhD in Cell Biology from the University of California, Davis followed by a postdoctoral fellowship at The Gladstone Institute in San Francisco. He also earned a B.S. in Bioengineering from the University of California at Berkeley. Throughout his career, Chris has worked closely with emerging startups in the Bay Area, from strategy development to execution of strategic partnerships, across many domains including antibody discovery, genomics, and immune-oncology cell therapy.

Johnson & Johnson

Head of JLABS, Bay Area

Chris Haskell, Ph.D.

Head of JLABS, Bay Area, Johnson & Johnson

Mark Federici

Director, Global BioInnovations, Biosciences Division, Thermo Fisher Scientific

Joe Panetta

President (Emeritus), Biocom

Gino Segre

Managing Director, Bakar Labs

Stephen Blair

Principal, Science & Technology Practice Director, CannonDesign

Universities Driving Innovation and Biotech Growth

Attracting, Retaining, and Supporting Top Talent, Developing Incubators for Startups, and Driving Growth Through Partnerships

Corinne Peek-Asa

Vice Chancellor for Research & Innovation, UCSD

Tracy Johnson

Dean of Life Sciences, UCLA

Jeffrey Roberts

Dean, SDSU College of Sciences, SDSU

Carmen Domingo

Dean of the College of Science and Engineering, SFSU

Scott Maloney

Director, Innovation & Private Sector Research Engage, Washington State University

Robert Fagnant

Associate Partner, Syska Hennessy Group

Vlad Pajkic

Partner, ZGF Architects

Life Sciences Real Estate Leasing Outlook: Lease Negotiations, Terms, Vacancies, and Flexibility

Navigating Supply vs Demand Dynamics, Tenant Preferences, and Strategies for Effective Space Utilization

Alicia Hinds

COO, Alloy Properties

Abby Mondani

VP, Oxford Properties

Meena Narayanan

Lead Scientist, Poseida Therapeutics, Inc. (A Member of Roche Group)

Chad Urie

Vice Chairman, JLL

Moderator

Martin Togni

Partner, Allen Matkins

High-Performing Labs: Building the Future of Lab Spaces

Delivering Flexible, Sustainable, and Advanced Lab Spaces

Scott Fees

Executive & Senior Vice President of Development, Wexford Science & Technology

Suzet McKinney

Investor, [Previously with Sterling Bay]

John Beuerlein

Sr Project Manager, DPR Construction

Brandon Fortier

Director, IMEG

Gul Dusi

National Lead, Life Sciences Project Development, JLL

Navigating Funding and Investment Opportunities: Strategies for Biotech Fundraising, Venture Capital, and Startup Financing

Exploring the Latest Trends in Securing Capital, Building Investor Relationships, and Overcoming Financial Challenges in the Evolving Biotech Landscape

Peter Dowley

SVP, Investments & Life Sciences, Kilroy Realty

Tariq Warsi

Venture Partner, Awaken Capital

Chris Yoo

General Partner, Xcellerant Ventures

Alex Browne

National Director, Research & Life Sciences, Transwestern

Howard Kozloff

Founder & CEO, Noblespace

AI in Biotech: Driving Innovation in R&D, Labs, and Delivery

The Role of Automation, Data, Robotics, and Emerging Technologies in the Future of Biotech

Ross Bundy

President and CEO, CRISPR QC

Adam Denmark

VP, Science & Tech Strategist/Director Lab Planning, SmithGroup

Peter Spier

Director of Preconstruction & Innovation, Hathaway Dinwiddie Construction Company

Remarks

Chris Orlando

President, VOC Associates

Remarks

Danielle Benford

Senior VP, VOC Associates

Two Day International Life Sciences Real Estate Conference in San Diego

What You’ll Learn at Bisnow’s International Life Sciences Conference

We are bringing our third annual International Life Sciences event to San Diego in 2025. With the life sciences industry continuing to redefine global innovation, this two-day international event will bring together thought leaders from biotech, real estate, investment, and research to explore strategies driving the next wave of growth. This conference serves as a critical platform for deal-making, industry insights, and networking opportunities across the intersection of biotech and commercial real estate.

Key Discussions Include:

Financing Biotech Growth: Navigate the complexities of fundraising, venture capital, and startup financing, alongside insights into accessing equity, structuring deals, and building lasting investor relationships.
Building for the Future: Explore the latest trends in designing and delivering adaptable lab spaces that meet tenant demands, attract end-users, and provide operational flexibility.
Innovative Lab Design & Construction: Learn how sustainability, efficiency, and technological innovation are shaping the future of lab development.
AI and Tech-Driven Labs: Discover how automation, robotics, and advanced technologies are transforming biotech research, design, and operations.
Scaling Life Sciences Companies: Gain insights into creating ecosystems, identifying clusters, and propelling startups toward growth and expansion.
San Diego’s Biotech Ecosystem: Dive into the developments defining San Diego’s emergence as a global biotech hub, including market trends, infrastructure, and policy impacts.
Universities as Innovation Catalysts: Understand how academic institutions are fostering talent, supporting startups, and driving regional biotech growth.
Leasing & Real Estate Outlook: Stay ahead of leasing trends, negotiation strategies, and space utilization solutions tailored to the evolving life sciences sector.
Pioneering Biotech Innovation: Hear from top biotech firms about cutting-edge advancements shaping the future of life sciences and their implications for real estate and industry collaboration.

Gain Exclusive Access To:

Expert panel discussions featuring leading developers, biotech executives, investors, and policymakers.
Targeted networking sessions designed to connect industry leaders, innovators, and decision-makers.
Keynote presentations and roundtable discussions on the most pressing topics impacting biotech and real estate.
Evening cocktail receptions to foster meaningful connections and partnerships.

Join us for this premier two-day conference and walk away with actionable insights to propel your projects, investments, and collaborations to the next level.

Get Your Professional Headshot Taken by popcam : If you're interested in getting your complimentary photo taken, come LinkedIn-ready!

See our past events here:

2024: International Life Sciences & Biotech Conference

2023: International Life Sciences & Biotech Conference

Good Reads:

What to Watch for in the Life Sciences Sector

Life Science Trends to Watch in 2025

Amid Historic Glut Of Lab Space, Big-Name Developers Teeing Up New Projects

A Snapshot of Some Companies Attending So Far:

Alexandria Real Estate Equities, Inc., Alloy Properties, Awaken Capital, Bakar Labs, Biocom, BioMed Realty, Breakthrough Properties, CARGO Therapeutics, CBRE, City of Pasadena, Cushman & Wakefield, Fred Hutch Cancer Center, Gilead Sciences, JLL, Johnson & Johnson, Kilroy Realty, King Street Properties, Longfellow Real Estate Partners, Noblespace, Oxford Properties Group, Poseida Therapeutics, SDSU, SFSU, SteelWave, Swinerton, Thermo Fisher Scientific, Trammell Crow Company, Transwestern, UCLA, Wexford Science + Technology, Whiting-Turner Contracting Co. ----- and hundreds more!

For questions, recommendations, comments, or press inquiries please email our Event Production team, Sam D'Angelo at samantha.dangelo@bisnow.com and Bora Altunay at bora.altunay@bisnow.com.

For speaker or sponsorship interest, please email our VP of West Coast, Stephanie Smith at stephanie.smith@bisnow.com.

To request disability-related accommodations, please contact thea.parkert@bisnow.com no later than 10 business days prior to the event.

Venue

Hilton San Diego Bayfront
1 Park Blvd
San Diego, CA 92101

Ballroom: Indigo Ballroom / Foyer / Terrace

Parking Information:

Self-parking $22

Valet parking $32

SUGGESTED HOTEL ACCOMMODATIONS:

After you purchase your conference ticket, take advantage of Bisnow's preferred rates / room block at nearby hotel. Please note, we only have a specified number of rooms allotted at the discount and they are on a first-come, first-serve basis.

Bisnow Group Block at the Marriott Residence Inn San Diego Downtown / Gaslamp Quarter -- 356 6th Avenue San Diego, CA 92101 (3 minute drive / 10 minute walk to the venue)

Last day to book via Bisnow Group Block is August 8th @ 12 am

Other nearby hotels:

Omni San Diego Hotel

Hard Rock Hotel San Diego

San Diego Marriott Gaslamp Quarter

Marriott Marquis San Diego Marina

Manchester Grand Hyatt San Diego

Get Directions

Agenda

September 9	Activity
6:00 PM 8:00 PM	Welcome Cocktail
September 10	Activity
9:00 AM 10:00 AM	Breakfast, Coffee & Networking
10:00 AM 10:45 AM	Keynote with Timothy Schoen, CEO, BioMed Realty
10:45 AM 11:30 AM	Driving Sustainability in Life Sciences and Biotech Implementing Sustainable Operational Solutions, Navigating Global Challenges, and Building Adaptable, Efficient Infrastructure to Support Real Estate Growth
11:30 AM 12:00 PM	Networking Break
12:00 PM 12:45 PM	Universities Driving Innovation and Biotech Growth Attracting, Retaining, and Supporting Top Talent, Developing Incubators for Startups, and Driving Growth Through Partnerships
12:45 PM 1:30 PM	Capital Markets Outlook, Transactions, Acquisitions, Deal-Making and Financing Sourcing Debt, Access To Equity, Navigating Real Estate Investments and Finding the Right Capital Partner
1:30 PM 2:30 PM	Lunch & Networking
2:30 PM 3:15 PM	Life Sciences Real Estate Leasing Outlook: Lease Negotiations, Terms, Vacancies, and Flexibility Navigating Supply vs Demand Dynamics, Tenant Preferences, and Strategies for Effective Space Utilization
3:15 PM 4:00 PM	High-Performing Labs: Building the Future of Lab Spaces Delivering Flexible, Sustainable, and Advanced Lab Spaces
4:00 PM 5:00 PM	Cocktail & Networking
September 11	Activity
8:00 AM 9:00 AM	Breakfast, Coffee & Networking
9:00 AM 9:45 AM	Navigating Funding and Investment Opportunities: Strategies for Biotech Fundraising, Venture Capital, and Startup Financing Exploring the Latest Trends in Securing Capital, Building Investor Relationships, and Overcoming Financial Challenges in the Evolving Biotech Landscape
9:45 AM 10:30 AM	AI in Biotech: Driving Innovation in R&D, Labs, and Delivery The Role of Automation, Data, Robotics, and Emerging Technologies in the Future of Biotech
10:30 AM 11:00 AM	Networking Break
11:00 AM 11:45 AM	Development, Construction, and Design Strategies Across All Lab Types Meeting Market Demands and Tenant Expectations in an Evolving Life Sciences Market
11:45 AM 12:30 PM	Helping Life Sciences Companies Scale Building Ecosystems, Identifying Clusters, Propelling Startup Growth and Expansion, and Helping Biotech Firms Reach Their Next Stage
12:30 PM 1:00 PM	Closing Networking

Interested in Sponsorship?

Contact stephanie.smith@bisnow.com to get information on sponsorship, pricing and availability at this event.

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Looking for quality commercial real estate prospects?

Biscred helps CRE professionals grow their network and close more deals with access to 4.4 million real estate contacts and filters built for how you actually prospect — by asset class, property count, location, and more.

Book a demo to get 25 custom-matched prospects based on your go-to-market focus.

P.S. Unlock Your Career Potential with SelectLeaders

Looking for the next step in your career or aiming to discover top talent? SelectLeaders is your destination! Whether you're seeking your next role or searching for exceptional talent, SelectLeaders connects ambitious professionals with industry-leading employers. Choose SelectLeaders to elevate your career search or talent acquisition

Want to get a recap of everything covered at the event?

Purchase the post-event summary and get the highlights sent to you in a post-event summary. Purchase here.

Call:	202-684-2034
Email:	eventregistration@bisnow.com